These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Genetic Evaluation of the Patients with Clinically Diagnosed Inborn Errors of Immunity by Whole Exome Sequencing: Results from a Specialized Research Center for Immunodeficiency in Türkiye. Erman B; Aba U; Ipsir C; Pehlivan D; Aytekin C; Cildir G; Cicek B; Bozkurt C; Tekeoglu S; Kaya M; Aydogmus C; Cipe F; Sucak G; Eltan SB; Ozen A; Barıs S; Karakoc-Aydiner E; Kıykım A; Karaatmaca B; Kose H; Uygun DFK; Celmeli F; Arikoglu T; Ozcan D; Keskin O; Arık E; Aytekin ES; Cesur M; Kucukosmanoglu E; Kılıc M; Yuksek M; Bıcakcı Z; Esenboga S; Ayvaz DÇ; Sefer AP; Guner SN; Keles S; Reisli I; Musabak U; Demirbas ND; Haskologlu S; Kilic SS; Metin A; Dogu F; Ikinciogulları A; Tezcan I J Clin Immunol; 2024 Jul; 44(7):157. PubMed ID: 38954121 [TBL] [Abstract][Full Text] [Related]
3. Contribution of high-throughput DNA sequencing to the study of primary immunodeficiencies. Picard C; Fischer A Eur J Immunol; 2014 Oct; 44(10):2854-61. PubMed ID: 25154746 [TBL] [Abstract][Full Text] [Related]
4. Whole exome sequencing in inborn errors of immunity: use the power but mind the limits. Bucciol G; Van Nieuwenhove E; Moens L; Itan Y; Meyts I Curr Opin Allergy Clin Immunol; 2017 Dec; 17(6):421-430. PubMed ID: 28938278 [TBL] [Abstract][Full Text] [Related]
5. Whole-Exome Sequencing-Based Approach for Germline Mutations in Patients with Inborn Errors of Immunity. Okano T; Imai K; Naruto T; Okada S; Yamashita M; Yeh TW; Ono S; Tanaka K; Okamoto K; Tanita K; Matsumoto K; Toyofuku E; Kumaki-Matsumoto E; Okamura M; Ueno H; Ogawa S; Ohara O; Takagi M; Kanegane H; Morio T J Clin Immunol; 2020 Jul; 40(5):729-740. PubMed ID: 32506361 [TBL] [Abstract][Full Text] [Related]
6. A single-center pilot study in Malaysia on the clinical utility of whole-exome sequencing for inborn errors of immunity. Ripen AM; Chear CT; Baharin MF; Nallusamy R; Chan KC; Kassim A; Choo CM; Wong KJ; Fong SM; Tan KK; Nachiappan JP; Teo KR; Chiow MY; Hishamshah M; Ghani H; Muralitharan RR; Mohamad SB Clin Exp Immunol; 2021 Nov; 206(2):119-128. PubMed ID: 34060650 [TBL] [Abstract][Full Text] [Related]
7. Exome sequencing greatly expedites the progressive research of Mendelian diseases. Zhang X Front Med; 2014 Mar; 8(1):42-57. PubMed ID: 24384736 [TBL] [Abstract][Full Text] [Related]
8. Development and Validation of Clinical Whole-Exome and Whole-Genome Sequencing for Detection of Germline Variants in Inherited Disease. Hegde M; Santani A; Mao R; Ferreira-Gonzalez A; Weck KE; Voelkerding KV Arch Pathol Lab Med; 2017 Jun; 141(6):798-805. PubMed ID: 28362156 [TBL] [Abstract][Full Text] [Related]
9. Clinical Utility of Whole Exome Sequencing and Targeted Panels for the Identification of Inborn Errors of Immunity in a Resource-Constrained Setting. Engelbrecht C; Urban M; Schoeman M; Paarwater B; van Coller A; Abraham DR; Cornelissen H; Glashoff R; Esser M; Möller M; Kinnear C; Glanzmann B Front Immunol; 2021; 12():665621. PubMed ID: 34093558 [TBL] [Abstract][Full Text] [Related]
10. Next generation sequencing (NGS)-based approach to diagnosing Algerian patients with suspected inborn errors of immunity (IEIs). Peng XP; Al-Ddafari MS; Caballero-Oteyza A; El Mezouar C; Mrovecova P; Dib SE; Massen Z; Smahi MC; Faiza A; Hassaïne RT; Lefranc G; Aribi M; Grimbacher B Clin Immunol; 2023 Nov; 256():109758. PubMed ID: 37678716 [TBL] [Abstract][Full Text] [Related]
11. Identification of Disease Susceptibility Alleles in the Next Generation Sequencing Era. DiStefano JK; Kingsley CB Methods Mol Biol; 2018; 1706():3-16. PubMed ID: 29423790 [TBL] [Abstract][Full Text] [Related]
12. Development of an evidence-based algorithm that optimizes sensitivity and specificity in ES-based diagnostics of a clinically heterogeneous patient population. Bauer P; Kandaswamy KK; Weiss MER; Paknia O; Werber M; Bertoli-Avella AM; Yüksel Z; Bochinska M; Oprea GE; Kishore S; Weckesser V; Karges E; Rolfs A Genet Med; 2019 Jan; 21(1):53-61. PubMed ID: 30100613 [TBL] [Abstract][Full Text] [Related]
13. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels. LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038 [TBL] [Abstract][Full Text] [Related]
14. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients. Lim EC; Brett M; Lai AH; Lee SP; Tan ES; Jamuar SS; Ng IS; Tan EC Hum Genomics; 2015 Dec; 9():33. PubMed ID: 26666243 [TBL] [Abstract][Full Text] [Related]
15. Use of whole exome and genome sequencing in the identification of genetic causes of primary immunodeficiencies. Chou J; Ohsumi TK; Geha RS Curr Opin Allergy Clin Immunol; 2012 Dec; 12(6):623-8. PubMed ID: 23095910 [TBL] [Abstract][Full Text] [Related]
16. The added value of WES reanalysis in the field of genetic diagnosis: lessons learned from 200 exomes in the Lebanese population. Jalkh N; Corbani S; Haidar Z; Hamdan N; Farah E; Abou Ghoch J; Ghosn R; Salem N; Fawaz A; Djambas Khayat C; Rajab M; Mourani C; Moukarzel A; Rassi S; Gerbaka B; Mansour H; Baassiri M; Dagher R; Breich D; Mégarbané A; Desvignes JP; Delague V; Mehawej C; Chouery E BMC Med Genomics; 2019 Jan; 12(1):11. PubMed ID: 30665423 [TBL] [Abstract][Full Text] [Related]